Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05696691 · ClinicalTrials.gov registry record · Phase 2
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
A Phase 2 study of Suicide, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05696691 is a Phase 2 study of Suicide that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 24 participants, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05696691, a Phase 2 study of Suicide, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized pilot trial is to assess the feasibility of administering a combination of 100mg intramuscular (IM) ketamine and Crisis Response Plan (a short psychosocial intervention) for patients with acute suicidality in the context of the Emergency Department setting. This study will assess a combination of a pharmacologic intervention and a psychosocial one. The pharmacologic intervention is a one-time dose of 100mg ketamine delivered intramuscularly (IM) while the patient is in the ED. The psychosocial intervention under study is a brief, patient-centered therapy which takes, on average, 30 minutes to administer. Both interventions will be administered only once. The main questions this study aims to answer are: * Determine if 100mg of IM ketamine and Crisis Response Plan in combination results in greater short-term reductions in suicidal ideation in adult patients who report acutely elevated suicide risk during an ED visit. * Examine potential weight-based dose response differences in the reductions in suicidal ideation to determine if future treatment protocols with IM ketamine may benefit from weight-based dosing.
Conditions Studied
Interventions
- DRUG Ketamine Hydrochloride
- BEHAVIORAL Crisis Response Plan
Study Locations (1)
Texas
- University Hospital - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2023-01-06 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05696691
The ClinicalTrials.gov registry entry for NCT05696691 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,990-participant average among 92 other Suicide trials with a reported enrollment target (100% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Ketamine Hydrochloride is the first listed.
NCT05696691 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05696691 about?
NCT05696691 is a clinical study titled "Ketamine & Crisis Response Plan for Suicidal Ideation in the ED". The goal of this randomized pilot trial is to assess the feasibility of administering a combination of 100mg intramuscular (IM) ketamine and Crisis Response Plan (a short psychosocial intervention) for patients with acute suicidality in the context of the Emergency Department setting. This study wil...
What is the current status of trial NCT05696691?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2023-01-06. Estimated completion is 2026-12-31.
What conditions does trial NCT05696691 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT05696691?
The interventions under investigation include: Ketamine Hydrochloride (DRUG), Crisis Response Plan (BEHAVIORAL).
Who is sponsoring clinical trial NCT05696691?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05696691 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suicide Risk Interventions
RECRUITING · Phase 2
-
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
RECRUITING · Phase 2
-
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
RECRUITING · Phase 2
-
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
RECRUITING · Phase 2
-
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
COMPLETED · Phase 2
-
Evaluation of a School-Based Training Program for Suicide Prevention
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.